BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients-Reference-Cited by-同舟云学术

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

Published:2011-09-27 Issue:8 Volume:105 Page:1230-1234
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Kote-Jarai Z, ,Leongamornlert D,Saunders E,Tymrakiewicz M,Castro E,Mahmud N,Guy M,Edwards S,O'Brien L,Sawyer E,Hall A,Wilkinson R,Dadaev T,Goh C,Easton D,Goldgar D,Eeles R

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2011383.pdf

Reference26 articles.

1. Agalliu I, Kwon EM, Zadory D, McIntosh L, Thompson J, Stanford JL, Ostrander EA (2007) Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer. Clin Cancer Res 13: 839–843

2. Anderson DE, Badzioch MD (1992) Breast cancer risks in relatives of male breast cancer patients. J Natl Cancer Inst 84: 1114–1117

3. Antoniou AC, Pharoah PP, Smith P, Easton DF (2004) The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91: 1580–1590

4. Edwards SM, Dearnaley DP, Ardern-Jones A, Hamoudi RA, Easton DF, Ford D, Shearer R, Dowe A, Eeles RA (1997) No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters. The CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group. Br J Cancer 76: 992–1000

5. Edwards SM, Dunsmuir WD, Gillett CE, Lakhani SR, Corbishley C, Young M, Kirby RS, Dearnaley DP, Dowe A, Ardern-Jones A, Kelly J, Spurr N, Barnes DM, Eeles RA (1998) Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Int J Cancer 78: 1–7

Cited by 327 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The 5-WS of targeting DNA-damage repair (DDR) pathways in prostate cancer;Cancer Treatment Reviews;2024-07

2. The Cost-Effectiveness of Germline BReast CAncer Gene Testing in Metastatic Prostate Cancer Followed by Cascade Testing of First-Degree Relatives of Mutation Carriers;Value in Health;2024-07

3. The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers;BJU International;2024-06-05

4. Next-Generation Sequencing Testing Can Save Generations of Lives;JCO Precision Oncology;2024-06

5. Prevalence of DNA-Repair Gene mutations in Mexican men with prostate cancer;Actas Urológicas Españolas (English Edition);2024-05